Events

Videos

Podcasts

Articles

Clinical

® Clinical Focus page includes a listing of all specialities covered across  OncLive.com, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, hematologic malignancies, and gynecologic cancers. Each individual specialty page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research.


Abemaciclib's Value in Treating HR+ Breast Cancer  

HR+ Breast Cancer: Pooled Analysis From MONARCH 2 and 3 

HR+ Breast Cancer: Resistance to Primary Therapy 

Factors in Deciding Treatment for HR+ Breast Cancer 

Heterogeneity of Metastatic HR+ Breast Cancer

Understanding Abemaciclib: A New CDK4/6 Inhibitor

CDK4/6 Inhibitor Combinations for HR+ mBC 

ER+/HER2+ Metastatic Breast Cancer

Future Directions: CDK4/6 Inhibitors in Breast Cancer

Treatment Selection for HR+ mBC

mBC: CDK4/6 Inhibitor Patient Selection/Sequencing

CDK4/6 Inhibitors in Breast Cancer: Ongoing Research

FDA Approval for Abemaciclib

MONARCH 3: Abemaciclib With Endocrine Therapy for mBC

MONARCH 1: Abemaciclib Monotherapy for HR+ mBC

Abemaciclib + Fulvestrant at Progression of HR+ mBC

Abemaciclib for ER+ mBC

CDK4/6 Inhibitors: Managing Toxicity in HR+ mBC

Clinical Experience: CDK4/6 Inhibitors in Breast Cancer

CDK 4/6 Inhibitors in Metastatic Breast Cancer

 Oncology Business Management condition center page is a comprehensive resource for news and expert insights on business-focused updates and topics in oncology practices, including diversity efforts, telehealth, gaps in care, payment models, and more. This page features news articles, interviews in written and video format, and podcasts that focus on updates and best practices with oncology business management.